pMRI-35 vector (V004467)

Basic Vector Information

Vector Name:
pMRI-35
Antibiotic Resistance:
Kanamycin
Length:
5028 bp
Type:
Cloning vector
Replication origin:
ori
Host:
Yeast
Source/Author:
Xie W, Yu H.
Promoter:
TEF1

pMRI-35 vector Map

pMRI-355028 bp6001200180024003000360042004800loxPLPP1 homologous armPGK1 terminatorFLAGTEF1 promoterT7 promoterMycTPS1 terminator derived from S. cerevisiaeLoxp sitekanMXori

pMRI-35 vector Sequence

LOCUS       40924_32280        5028 bp DNA     circular SYN 18-DEC-2018
DEFINITION  Cloning vector pMRI-35, complete sequence.
ACCESSION   .
VERSION     .
KEYWORDS    .
SOURCE      synthetic DNA construct
  ORGANISM  synthetic DNA construct
REFERENCE   1  (bases 1 to 5028)
  AUTHORS   Xie W, Yu H.
  TITLE     Developing a sequential repressing-inducing control strategy for 
            improving carotenoids production in Saccharomyces cerevisiae
  JOURNAL   Unpublished
REFERENCE   2  (bases 1 to 5028)
  AUTHORS   Xie W, Yu H.
  TITLE     Direct Submission
  JOURNAL   Submitted (26-FEB-2014) Department of Chemical and Biological 
            Engineering, Zhejiang University, Institute of Bioengineering, 34 
            TianMuShan Road, Hangzhou, Zhejiang 310028, China
REFERENCE   3  (bases 1 to 5028)
  TITLE     Direct Submission
REFERENCE   4  (bases 1 to 5028)
  AUTHORS   .
  TITLE     Direct Submission
COMMENT     SGRef: number: 1; type: "Journal Article"; journalName: 
            "Unpublished"
COMMENT     SGRef: number: 2; type: "Journal Article"; journalName: "Submitted 
            (26-FEB-2014) Department of Chemical and Biological Engineering, 
            Zhejiang University, Institute of Bioengineering, 34 TianMuShan 
            Road, Hangzhou, Zhejiang 310028, China"
COMMENT     SGRef: number: 3; type: "Journal Article"
FEATURES             Location/Qualifiers
     source          1..5028
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     protein_bind    22..55
                     /label=loxP
                     /note="Cre-mediated recombination occurs in the 8-bp core 
                     sequence (ATGTATGC) (Shaw et al., 2021)."
     misc_feature    113..917
                     /label=LPP1 homologous arm
                     /note="LPP1 homologous arm"
     terminator      complement(947..1217)
                     /label=PGK1 terminator
                     /note="transcription terminator for 3-phosphoglycerate
                     kinase gene"
     CDS             complement(1236..1259)
                     /label=FLAG
                     /note="FLAG(R) epitope tag, followed by an enterokinase
                     cleavage site"
     promoter        1911..2318
                     /label=TEF1 promoter
                     /note="promoter for EF-1-alpha"
     promoter        2339..2357
                     /label=T7 promoter
                     /note="promoter for bacteriophage T7 RNA polymerase"
     CDS             2375..2404
                     /label=Myc
                     /note="Myc (human c-Myc proto-oncogene) epitope tag"
     regulatory      2430..2762
                     /label=TPS1 terminator derived from S. cerevisiae
                     /note="TPS1 terminator derived from S. cerevisiae"
                     /regulatory_class="terminator"
     misc_feature    2784..2817
                     /label=Loxp site
                     /note="Loxp site"
     protein_bind    complement(2784..2817)
                     /label=loxP
                     /bound_moiety="Cre recombinase"
                     /note="Cre-mediated recombination occurs in the 8-bp core 
                     sequence (GCATACAT)."
     gene            2863..4219
                     /label=kanMX
                     /note="yeast selectable marker conferring kanamycin
                     resistance (Wach et al., 1994)"
     rep_origin      complement(4352..4940)
                     /direction=LEFT
                     /label=ori
                     /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of 
                     replication"

This page is informational only.